ARBUTUS BIOPHARMA CORPORATION SUBSCRIPTION AGREEMENT FOR PREFERRED SHARESSubscription Agreement • October 3rd, 2017 • Roivant Sciences Ltd. • Pharmaceutical preparations • British Columbia
Contract Type FiledOctober 3rd, 2017 Company Industry JurisdictionThe undersigned (the Subscriber) hereby irrevocably subscribes for and agrees to purchase from Arbutus Biopharma Corporation (the Company) that number of preferred shares in the capital of the Company (the Preferred Shares) set out below for the aggregate subscription amount set out below, representing a subscription price per Preferred Share of $100.00 (the Subscription Price), on the terms and subject to the conditions set out in this Subscription Agreement (as defined below). The Subscriber agrees to be bound by the terms and conditions set forth in the attached “Terms and Conditions of Subscription for Preferred Shares”.